SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-19-001660
Filing Date
2019-03-07
Accepted
2019-03-07 16:21:15
Documents
88
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K crvs-20181231x10k.htm 10-K 3177863
2 EX-10.1(H) crvs-20181231ex101h5927c.htm EX-10.1(H) 36683
3 EX-10.11(A) crvs-20181231ex1011adf2b.htm EX-10.11(A) 37317
4 EX-10.11(B) crvs-20181231ex1011b8357.htm EX-10.11(B) 92642
5 EX-21.1 crvs-20181231ex2119d070c.htm EX-21.1 11995
6 EX-23.1 crvs-20181231ex231c362e4.htm EX-23.1 2394
7 EX-31.1 crvs-20181231ex3119480d3.htm EX-31.1 17976
8 EX-31.2 crvs-20181231ex3123d3162.htm EX-31.2 18741
9 EX-32.1 crvs-20181231ex3216dd7df.htm EX-32.1 9863
10 GRAPHIC crvs20181231ex101h5927c001.jpg GRAPHIC 4731
11 GRAPHIC crvs20181231x10k001.jpg GRAPHIC 127292
12 GRAPHIC crvs20181231x10k002.jpg GRAPHIC 23627
13 GRAPHIC crvs20181231x10k003.jpg GRAPHIC 37074
14 GRAPHIC crvs20181231x10k004.jpg GRAPHIC 46439
  Complete submission text file 0001558370-19-001660.txt   10505543

Data Files

Seq Description Document Type Size
15 EX-101.INS crvs-20181231.xml EX-101.INS 2257756
16 EX-101.SCH crvs-20181231.xsd EX-101.SCH 56301
17 EX-101.CAL crvs-20181231_cal.xml EX-101.CAL 59406
18 EX-101.DEF crvs-20181231_def.xml EX-101.DEF 163363
19 EX-101.LAB crvs-20181231_lab.xml EX-101.LAB 519927
20 EX-101.PRE crvs-20181231_pre.xml EX-101.PRE 368571
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37719 | Film No.: 19666093
SIC: 2834 Pharmaceutical Preparations